Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.021,66
0,24%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ ESSA Pharma Inc (EPIX) ESSA Pharma Inc (EPIX) Notizie

ESSA Pharma Inc

EPIX
1,83
0,07 (3,98%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/11/202421:30EDGAR2Form 8-K - Current report
01/11/202401:57PRNUSESSA Pharma Announces Termination of Phase 2 Study..
07/10/202421:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202423:19PRNCAESSA Pharma Presents Updated Phase 1/2 Masofaniten..
11/9/202422:05PRNCAESSA Pharma to Present at the 2024 Cantor Global Healthcare..
09/9/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202422:17EDGAR2Form 144 - Report of proposed sale of securities
05/8/202413:01EDGAR2Form 8-K - Current report
05/8/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/8/202413:00PRNCAESSA Pharma Provides Corporate Update and Reports Financial..
08/7/202422:05PRNCAESSA Pharma to Present at the JonesHealthcare Seaside Summit
30/5/202414:00PRNCAESSA Pharma to Present at the Jefferies Global Healthcare..
14/5/202413:01EDGAR2Form 8-K - Current report
14/5/202413:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202413:00PRNCAESSA Pharma Provides Corporate Update and Reports Financial..
06/5/202423:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/4/202414:00PRNCAESSA Pharma to Present at the 2024 Bloom Burton & Co...
08/3/202402:13PRNUSESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING..
07/3/202423:18EDGAR2Form 8-K - Current report
06/3/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202413:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202413:01EDGAR2Form 8-K - Current report
13/2/202413:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..
07/2/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:00PRNCAESSA Pharma to Present at the Oppenheimer 34th Annual..
29/1/202415:15EDGAR2Form 8-K - Current report
26/1/202422:40EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202422:27EDGAR2Form DEF 14A - Other definitive proxy statements
25/1/202416:00PRNUSESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386)..
23/1/202422:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202402:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:19EDGAR2Form 144 - Report of proposed sale of securities
16/1/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202402:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202422:04EDGAR2Form 144 - Report of proposed sale of securities
12/12/202313:01EDGAR2Form 8-K - Current report
12/12/202313:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
12/12/202313:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..
Apertura: 1,74 Min: 1,73 Max: 1,855
Chiusura: 1,76

La tua Cronologia

NASDAQ
EPIX
ESSA Pharma
AQSE
MAX
MaxRets Ventures
EU
AAA
Alan Allman Associates
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network